Said Afqir Selected Research

Said Afqir Research Topics

16	Neoplasms (Cancer) 01/2022 - 02/2011
7	Breast Neoplasms (Breast Cancer) 12/2021 - 04/2009
4	Ovarian Neoplasms (Ovarian Cancer) 12/2021 - 01/2017
3	Neoplasm Metastasis (Metastasis) 01/2022 - 04/2009
2	Hepatocellular Carcinoma (Hepatoma) 04/2021 - 10/2020
1	Colorectal Neoplasms (Colorectal Cancer) 01/2022
1	Ovarian Epithelial Carcinoma 01/2021
1	Inflammation (Inflammations) 01/2021
1	COVID-19 12/2020
1	Granulosa Cell Tumor 05/2020
1	Dysbiosis 04/2020
1	Anastomotic Leak 04/2020
1	Rectal Neoplasms (Rectal Cancer) 05/2019
1	Starvation 01/2018
1	Obesity 01/2017
1	Triple Negative Breast Neoplasms 01/2017
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2016
1	Amenorrhea 01/2016
1	Prostatic Neoplasms (Prostate Cancer) 12/2012
1	Lung Neoplasms (Lung Cancer) 02/2011
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 02/2011
1	Dermatitis 04/2009
1	Urinary Bladder Neoplasms (Bladder Cancer) 04/2009
1	Nasopharyngeal Carcinoma 01/2009
1	Seminoma 11/2008
1	Renal Insufficiency (Renal Failure) 11/2008

8	Biomarkers (Surrogate Marker)IBA 12/2021 - 04/2017
4	Pharmaceutical PreparationsIBA 12/2020 - 01/2016
3	PlatinumIBA 12/2021 - 04/2009
3	Hormones (Hormone)IBA 10/2021 - 01/2017
2	Immune Checkpoint InhibitorsIBA 12/2021 - 04/2020
2	AntigensIBA 12/2021 - 05/2020
2	Docetaxel (Taxotere)FDA Link 01/2016 - 12/2012
2	Carboplatin (JM8)FDA LinkGeneric 02/2011 - 11/2008
1	Bevacizumab (Avastin)FDA Link 01/2022
1	Monoclonal AntibodiesIBA 12/2021
1	B7-H1 AntigenIBA 12/2021
1	Immunoconjugates (Immunoconjugate)IBA 12/2021
1	Programmed Cell Death 1 ReceptorIBA 10/2020
1	inhibin BIBA 05/2020
1	CollagenIBA 04/2020
1	Trastuzumab (Herceptin)FDA Link 01/2017
1	Abiraterone AcetateIBA 12/2012
1	Denosumab FDA Link 12/2012
1	Bortezomib (Velcade)FDA Link 12/2012
1	sipuleucel-T (APC8015)FDA Link 12/2012
1	belinostatIBA 12/2012
1	Cisplatin (Platino)FDA LinkGeneric 02/2011
1	AnthracyclinesIBA 04/2009